Artera
Curated by SignalAI-derived prognostic biomarker test for cancer detection
Overview
AI-derived prognostic biomarker test for cancer detection. The company offers an AI-enabled test called the ArteraAI prostate test, which provides predictive and prognostic results for patients with localized prostate cancer. The test analyzes multiple characteristics of the individual patient, empowering doctors with personalized data for treatment planning.
Key facts
- Founded
- 2021
- Headquarters
- Menlo Park, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 1 product or service
- Sign up to view
- Commercial model
- Sign up to view
Contact
- Sign up to view
Open roles
29 rolesCustomer Success Representative I (West Coast Region)
United States · On-site · Volunteer
Chief Medical Officer (CMO)
United States · On-site · Volunteer
Senior Medical Science Liaison - Western US
United States · On-site · Volunteer